A Phase I, Multicenter, Open-label Study of Oral ABL001 in Patients With Chronic Myelogenous Leukemia (CML) or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Latest Information Update: 13 Feb 2025
At a glance
Most Recent Events
- 12 Dec 2023 Results (n=115) assessing Efficacy, Safety, and Tolerability of Asciminib (ASC) Monotherapy in Patients (Pts) with Philadelphia Chromosome Positive Chronic Myeloid Leukemia in Chronic Phase presented at the 65th American Society of Hematology Annual Meeting and Exposition
- 12 Dec 2023 Results (cutoff:Mar 14, 2023),presented at the 65th American Society of Hematology Annual Meeting and Exposition
- 21 Mar 2023 Status changed from active, no longer recruiting to completed.